DOCS Stock Overview
Designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Dr. Martens plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.85 |
| 52 Week High | UK£1.69 |
| 52 Week Low | UK£0.62 |
| Beta | 0.0078 |
| 1 Month Change | 26.89% |
| 3 Month Change | -10.53% |
| 1 Year Change | -48.37% |
| 3 Year Change | -82.28% |
| 5 Year Change | n/a |
| Change since IPO | -81.02% |
Recent News & Updates
Recent updates
Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?
Mar 02Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price
Dec 01Are Dr. Martens plc (LON:DOCS) Investors Paying Above The Intrinsic Value?
Aug 24Investors Can Find Comfort In Dr. Martens' (LON:DOCS) Earnings Quality
Jun 24Does This Valuation Of Dr. Martens plc (LON:DOCS) Imply Investors Are Overpaying?
Apr 29Shareholder Returns
| DOCS | GB Luxury | GB Market | |
|---|---|---|---|
| 7D | 7.3% | -4.1% | 0.5% |
| 1Y | -48.4% | -45.6% | 6.3% |
Return vs Industry: DOCS underperformed the UK Luxury industry which returned -45.6% over the past year.
Return vs Market: DOCS underperformed the UK Market which returned 6.3% over the past year.
Price Volatility
| DOCS volatility | |
|---|---|
| DOCS Average Weekly Movement | 10.1% |
| Luxury Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: DOCS has not had significant price volatility in the past 3 months.
Volatility Over Time: DOCS's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO |
|---|---|---|
| 1945 | 2,591 | Kenny Wilson |
| Website |
|---|
| www.drmartensplc.com |
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name.
Dr. Martens plc Fundamentals Summary
| DOCS fundamental statistics | |
|---|---|
| Market cap | UK£821.49m |
| Earnings (TTM) | UK£103.20m |
| Revenue (TTM) | UK£977.50m |
8.0x
P/E Ratio0.8x
P/S RatioIs DOCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCS income statement (TTM) | |
|---|---|
| Revenue | UK£977.50m |
| Cost of Revenue | UK£362.30m |
| Gross Profit | UK£615.20m |
| Other Expenses | UK£512.00m |
| Earnings | UK£103.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 62.94% |
| Net Profit Margin | 10.56% |
| Debt/Equity Ratio | 86.5% |
How did DOCS perform over the long term?
See historical performance and comparison